Access & Early Diagnosis Track

26th November – 16:00 – 17:15 – Session III
Education Track

Value from Organizational Perspective Context Matters

Which methodologies are currently in place to analyze organizational value of health technologies? How can they be integrated and provide value for new approaches of personalized medicine? This session will review and analyse existing frameworks and values from the organisational perspective including EUnetHTA core Model, ADHopHTA and INTEGRATE-HTA framework.

Do they suffice to define the impact and the value Personalised medicine solutions (cell and gene therapies, CAR-Ts,…) could bring to the health care systems? Do we need to think about new frameworks and services? Are those frameworks applicable to all the countries and systems? Which are the challenges of applying personalised medicine technologies in LMIcs?

Chair

Marco Marchetti

Marco Marchetti

Istituto Superiore di Sanità, Rome ISS

Panel

Debjani Mueller

Debjani Mueller

CMeRC HTA-Unit, University of Witwatersrand, South Africa and CREMS, LIUC University, Italy

Gert Jan van der Wilt

Gert Jan van der Wilt

Professor of Health Technology Assessment, Department for Health Evidence, Radboud University Medical Center

Ansgar Hebborn

Ansgar Hebborn

Head of Global HTA & Payment Policy at Roche

Fabien Calvo

Fabien Calvo

Chief Scientific Officer, Cancer Core Europe